IESET.
Hypotheses·healthcare·cuba_health_outcomes_vs_latam_peers

Cuban life expectancy and infant mortality outcomes 1960-2000 outperformed Latin American middle-income peers despite sanctions, demonstrating socialist health-system superiority.

SUPPORTEDengine/runs/cuba_health_outcomes_vs_latam_peers

SUPPORTED — Cuba's 2000 LE was 75.9y vs LATAM peer mean 72.8y (gap +3.1y, threshold +1.0y). Cuban IMR was 6.8/1k vs peer mean 21.1/1k (ratio 0.32, threshold ≤0.50). LE rank 3/12, IMR rank 1/12. IMR-ratio improved (0.36 → 0.32) but the LE gap NARROWED (+6.0y → +3.1y) — peers caught up on life expectancy.

confidence cueThis is a clear pass for the claim as written. It still applies only to this sample, period, and method.

policy briefNeeds review

In ordinary language

Over a long period, do more market-oriented institutions translate into higher income or productivity, once the comparison looks beyond a single success story?

plain answer

The data clearly moved in the predicted direction. Cuba's 2000 LE was 75.9y vs LATAM peer mean 72.8y (gap +3.1y, threshold +1.0y).

why it matters

This matters because healthcare claims should change belief only when they survive a pre-declared empirical test.

how the test works

It compares 12 country or place units from 1960 to 2000, using a descriptive design.

what was measured
What changed
  • Cuba socialist indicator
What we checked
  • Life expectancy at birth
  • Infant mortality per 1000
  • Life expectancy who
what this does not prove

A single test is not the whole truth. It narrows the claim under a specific sample, time period, and method. Strong policy conclusions need the pattern to survive nearby tests, alternative data, and serious objections.

verification

2 input datasets, 0 unresolved missing series, provenance status: partial provenance.

Results

engine/runs/cuba_health_outcomes_vs_latam_peers
Loading chart…

Who has skin in the game — schools predicting on this

3 schools list this hypothesis as a test of their position. The chips below are school-level scoreboard outcomes, not a second hypothesis verdict.

hypothesis verdict vs scoreboard outcome

The banner verdict judges this hypothesis as written. The scoreboard asks whether each school's polarity-corrected prediction was right. Raw status is not a school win: SUPPORTED supports schools that needed SUPPORTED, but refutes schools that needed REFUTED.

Pre-registration

pre-registered
first-spec commit 4c8ce8e · 2026-07-18T22:11:21Z

Cuban life expectancy and infant mortality outcomes 1960-2000 outperformed Latin American middle-income peers despite sanctions, demonstrating socialist health-system superiority.

Falsification criterion — what would disprove this

set before the run · honoured after

This hypothesis is considered falsified if:

PRIMARY 1 (life expectancy, dispositive): Cuba's life expectancy at birth in 2000 minus the LATAM peer-pool mean in 2000 must be at least +1.0 year. PRIMARY 2 (infant mortality, dispositive): Cuba's IMR in 2000 must be at most 50% of the LATAM peer-pool mean (CUB / peer_mean <= 0.50). SUPPORTED if BOTH primaries hold AND Cuba's gap on at least one metric is more favourable in 2000 than in 1960 (so Cuba "pulled away" rather than just starting ahead). PARTIAL if exactly one primary holds. REFUTED if neither primary holds. INFORMATIVE: Cuba's rank within the 12-country pool at 2000 on each metric, plus 1991-2000 sub-period (post-Soviet-subsidy) trajectory. METHOD_VALID: requires WDI coverage for at least 8 of 11 peers at the 2000 endpoint; WHO GHO independent cross-check noted as unavailable for the full window (series begins ~2000).

formal test & threshold
test:      cuba_vs_latam_peer_mean_endpoint_dual_threshold_2000
threshold: PRIMARY: (le_cub_2000 - le_peer_mean_2000) >= 1.0 AND (imr_cub_2000 / imr_peer_mean_2000) <= 0.50 AND ((le_gap_2000 > le_gap_1960) OR (imr_ratio_2000 < imr_ratio_1960))

Method

Template
descriptive
Sample
12 countries · 19602000
Evidence type
associational

Descriptive cross-country comparison of CUB vs income-matched LATAM peers 1960-2000 on life expectancy and infant mortality. Plot trajectories with sanctions/embargo annotations; report rank-position of CUB within peer distribution at 5-year intervals. Cuban official data quality flagged as measurement caveat — sensitivity using WHO independent estimates. Not causal — does not separate health-system architecture from Soviet subsidies channel (subsidies ended 1991 makes 1991-2000 a useful sub-period).

Data

VariableSourceTransform
life_expectancy_at_birth
outcome
world_bank_wdi:SP.DYN.LE00.INtier 2
level
infant_mortality_per_1000
outcome
world_bank_wdi:SP.DYN.IMRT.INtier 2
log
life_expectancy_who
outcome
who_gho:life_expectancy_at_birthtier 1
level
cuba_socialist_indicator
treatment
constructed:indicator = 1 for CUB; 0 for income-matched LATAM peer pool.tier 5
indicator
log_gdp_per_capita
control
world_bank_wdi:NY.GDP.PCAP.KDtier 2
log
log_health_expenditure_per_capita
control
world_bank_wdi:SH.XPD.CHEX.PC.CDtier 2
log

ready  ·  pending  ·  reconstruct-needed

Detailed result card

Cuban health outcomes vs LATAM peers, 1960-2000

Verdict: SUPPORTED — Cuba's 2000 LE was 75.9y vs LATAM peer mean 72.8y (gap +3.1y, threshold +1.0y). Cuban IMR was 6.8/1k vs peer mean 21.1/1k (ratio 0.32, threshold ≤0.50). LE rank 3/12, IMR rank 1/12. IMR-ratio improved (0.36 → 0.32) but the LE gap NARROWED (+6.0y → +3.1y) — peers caught up on life expectancy.

Endpoint comparison

| Metric | Cuba 1960 | Cuba 2000 | Peer mean 1960 | Peer mean 2000 | 2000 gap / ratio | |---|---:|---:|---:|---:|---:| | Life expectancy (y) | 63.3 | 75.9 | 57.3 | 72.8 | +3.1y (need ≥ +1.0y) | | Infant mortality (per 1k) | 36.6 | 6.8 | 102.8 | 21.1 | 0.32 (need ≤ 0.50) |

At 2000 Cuba ranks #3/12 on life expectancy (higher = better) and #1/12 on infant mortality (lower = better) within the 12-country pool (Cuba + 11 peers).

Did Cuba pull away or just start ahead?

  • LE gap 1960: +6.0y → 2000: +3.1y (change -2.9y).
  • IMR ratio 1960: 0.36 → 2000: 0.32 (improvement +0.03).
  • Pulled away on at least one metric: True.

Soviet-subsidy sub-period (1991-2000)

Soviet bloc collapse cut Cuban subsidies hard from 1991. If the gap held or widened in 1991-2000, that points more towards system-architecture; if the gap narrowed, subsidies were doing more of the work.

  • LE gap 1991: +3.5y → 2000: +3.1y.
  • IMR ratio 1991: 0.32 → 2000: 0.32.

Method

Descriptive endpoint comparison; no causal panel estimator. The thresholds come from a fair-reader interpretation of 'outperform' for a primary-care-emphasising system: at least one year better on LE at the endpoint, half-or-less infant-mortality vs the peer pool. The peer pool is the spec's 11 LATAM middle-income countries (MEX, BRA, ARG, CHL, COL, VEN, DOM, ECU, PER, URY, CRI). Method-validity gate: at least 8 of 11 peers must have data at the 2000 endpoint.

Caveats

  • WDI back-fills the Cuban 1960-2000 series from Cuban government sources. WHO GHO independent life-expectancy estimates start around 2000, so a contemporaneous WHO cross-check across the full window is not possible from current vintages.
  • This is descriptive only — it does not separate Cuban primary-care architecture from Soviet subsidy effects (1960-1991) or from primary-care diffusion across peer countries (Costa Rica's primary care expanded substantially over the same window and tracks Cuba closely).
  • The 2000 ranking conditions on whichever peer countries had both an embargo-style shock and a non-Cuban political system; Venezuela's 1999 oil collapse and Argentina's 2001 crisis sit at the back end of this window.

Provenance

  • world_bank_wdi:SP.DYN.LE00.IN
  • world_bank_wdi:SP.DYN.IMRT.IN

See manifest.yaml for exact vintages. Reproduces from replication.py.

Strongest opposing argument

Every hypothesis ships with its charitable opposing argument. The framework earns credibility by handling objections at their strongest, not weakest.

Notes

Stub seeded from a Marxist-Leninist school prediction about Cuban health-system superiority. Cuban official data quality is contested; needs human review of WHO/PAHO independent estimates and embargo controls.

Authored framework. Read the transparency note.